The Investor Relations website contains information about Kala Pharmaceuticals, Inc.'s business for stockholders, potential investors, and financial analysts.

Kala Pharmaceuticals, Inc. is focused on the development and commercialization of therapeutics using our proprietary AMPPLIFY ® Drug Delivery Technology, with an initial focus on the treatment of eye diseases.

Click here now. A look at the daily price movement shows that the last close reads $7.61, with intrad Company Name: Kala Pharmaceuticals, Stock Symbol: KALA, Industry: Biotechs, Total Posts: 65, Last Post: 4/12/2021 11:08:08 AM 6 Wall Street analysts have issued ratings and price targets for Kala Pharmaceuticals in the last 12 months. Their average twelve-month price target is $21.83, predicting that the stock has a possible upside of 192.28%. The high price target for KALA is $47.00 and the low price target for KALA is $10.00. Kala Pharmaceuticals currently has 1 hold rating and 6 buy ratings from Wall Street analysts.

Kala pharmaceuticals stock

The Kala Pharmaceuticals Inc stock price gained 4.27% on the last trading day (Friday, 9th Apr 2021), rising from $7.26 to $7.57. , and has now gained 4 days in a row.It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. 2020-10-28 Kala Pharmaceuticals. stock was originally listed at a price of $18.49 in Jul 20, 2017. If you had invested in Kala Pharmaceuticals stock at $18.49, your return over the last 3 years would have been -60.74%, for an annualized return of -26.77%. A high-level overview of Kala Pharmaceuticals, Inc. (KALA) stock.

The grants were approved by the Compensation Committee and were made as an inducement material to each employee entering into employment with Kala Pharmaceuticals in accordance with … Find the latest Kala Pharmaceuticals, Inc. (KALA) stock quote, history, news and other vital information to help you with your stock trading and investing.

Kala Pharmaceuticals Inc stock price down 1.84% on Friday (Updated on April 16, 2021) Buy candidate since 2021-04-15 Loss -1.84% PDF The Kala Pharmaceuticals Inc stock price fell by -1.84% on the last day (Friday, 16th Apr 2021) from $7.61 to $7.47. During the day the stock fluctuated 4.80% from a day low at $7.29 to a day high of $7.64.

Considering analysts have assigned the stock a price target range of $10-$49 as the low and high respectively, we find the trailing 12-month average consensus price target to be $20.71. Company Name: Kala Pharmaceuticals, Stock Symbol: KALA, Industry: Biotechs, Total Posts: 61, Last Post: 4/5/2021 4:56:15 PM Get Kala Pharmaceuticals Inc (KALA:NASDAQ) real-time stock quotes, news, price and financial information from CNBC.

Kala Pharmaceuticals, Inc. (NASDAQ:KALA) is possibly approaching a major achievement in its business, so we would like to shine some light on the company.Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies using its proprietary nanoparticle-based Mucus Penetrating Particles (MPP) technology for the treatment of eye

The company’s stock price has collected -22.87% of loss in the last five trading sessions. Press Release reported on 03/18/21 that Kala Pharmaceuticals Reports I Kala Pharmaceuticals currently has 1 hold rating and 6 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe KALA will outperform the market and that investors should add to their positions of Kala Pharmaceuticals.

Kala Pharmaceuticals Inc. company facts, information and financial ratios from MarketWatch. Kala Pharmaceuticals, Inc. Common Stock (KALA) After-Hours Stock Quotes - Nasdaq offers after-hours quotes and extended trading activity data for US and global markets. WATERTOWN, Mass.-- (BUSINESS WIRE)--Kala Pharmaceuticals, Inc. (NASDAQ:KALA), today announced that the Company granted non-statutory stock options to new employees as inducement awards outside the Compan 2 weeks ago - Business Wire Kala Pharmaceuticals Announces Preferred Position for EYSUVIS™ on Cigna Kala Pharmaceuticals stock is trading at 6.87 as of the 12th of April 2021, a -9.25 percent decrease since the beginning of the trading day. The stock's open price was 7.57. Kala Pharmaceuticals has a very high chance of experiencing financial distress in the next few years of operation.
23 dollar i kr

View which stocks have been most impacted by COVID-19. What price target have analysts set for KALA?

Use the PitchBook Platform to explore the full profile. View Kala Pharmaceuticals, Inc. KALA investment & stock information. Get the latest Kala Pharmaceuticals, Inc. KALA detailed stock quotes, stock data, Stock Symbol NASDAQ:KALA; Company Type For Profit. Contact Email info@ kalarx.com; Phone Number 1(781) 996-5252.
Vad jobbar maskiningenjör med

2021-04-06 · Detailed statistics for Kala Pharmaceuticals (KALA) stock, including valuation metrics, financial numbers, share information and more.

Nasdaq 100. Data is currently not available. $7.57. +0.31 (+4.27%) DATA AS OF Apr 09, 2021.

Bravida lidköping

Kala Pharmaceuticals' stock is owned by many different institutional and retail investors. Top institutional shareholders include Mesirow Financial Investment Management Inc. (0.07%). Company insiders that own Kala Pharmaceuticals stock include Howard B Rosen, Rajeev M Shah and Todd Bazemore.

2021-04-12 · Get the latest Kala Pharmaceuticals (KALA) stock price quote with real-time news, financials, charts and other important investing information. Kala Pharmaceuticals stock is trading at 6.87 as of the 12th of April 2021, a -9.25 percent down since the beginning of the trading day.